A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection

NACompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1997

Primary Completion Date

March 31, 2000

Study Completion Date

March 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Hydroxyurea

DRUG

Nelfinavir mesylate

DRUG

Stavudine

DRUG

Didanosine

Trial Locations (1)

94110

Univ of California at San Francisco Gen Hosp, San Francisco

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY